Saxagliptin Hydrochloride: Medgend

Saxagliptin Hydrochloride FDA Approved Drugs

KOMBIGLYZE XR [Metformin Hydrochloride^{C₄H₁₁N₅ClH} : Saxagliptin Hydrochloride^{C₁₈H₂₅N₃O₂ClH}]

1gm : eq 2.5mg base (oral tablet, extended release)

1gm : eq 5mg base (oral tablet, extended release)

500mg : eq 5mg base (oral tablet, extended release)

Astrazeneca Ab^{Nov 5, 2010}

Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both saxagliptin and metformin is appropriate.
Method for treating type ii diabetes mellitus by administering saxagliptin in combination with metformin.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ONGLYZA [Saxagliptin Hydrochloride^{C₁₈H₂₅N₃O₂ClH}]

eq 2.5mg base (oral tablet)

eq 5mg base (oral tablet)

Astrazeneca Ab^{Jul 31, 2009}

Method for treating type ii diabetes by administering saxagliptin.
Method for treating type ii diabetes mellitus by administering saxagliptin alone or in combination with insulin, metformin, a thiazolidinedione, glyburide or metformin plus a sulfonylurea.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

QTERN [Dapagliflozin Propanediol^{C₂₁H₂₅ClO₆C₃H₈O₂H₂O} : Saxagliptin Hydrochloride^{C₁₈H₂₅N₃O₂ClH}]

eq 10mg base : eq 5mg base (oral tablet)

Astrazeneca Ab^{Feb 27, 2017}

Method for treating type 2 diabetes mellitus (t2dm) in patients who are already treated with dapagliflozin and saxagliptin.
Method for treating type 2 diabetes mellitus (t2dm) in patients who have inadequate control with dapagliflozin.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.